$65.39 -$0.92 (-1.4%)

02:45 PM EDT on 06/02/20

NovoCure (NASDAQ:NVCR)

CAPS Rating: 5 out of 5

Current Price $65.39 Mkt Cap $6.7B
Open $66.55 P/E Ratio 736.23
Prev. Close $66.31 Div. (Yield) $0.00 (0.0%)
Daily Range $64.57 - $67.09 Volume 519,891
52-Wk Range $53.40 - $98.84 Avg. Daily Vol. 811,763

Caps

How do you think NASDAQ:NVCR will perform against the market?

Add Stock to CAPS Watchlist

All Players

192 Outperform
1 Underperform
 

All-Star Players

92 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NVCR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

kmhjv3rt (29.60)
Submitted July 15, 2019

Fight cancer with electric shock? This is interesting.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:NVCR VS S&P 500 (SPY)

NASDAQ:NVCR Summary

Fools bullish on NASDAQ:NVCR are also bullish on:

Fools bearish on NASDAQ:NVCR are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NVCR.

Recs

0
Member Avatar holdsteady (69.59) Submitted: 6/2/2020 11:19:55 AM : Outperform Start Price: $65.26 NASDAQ:NVCR Score: -0.70

Market leader in non-invasive cancer therapy, several treatments in phase 3 trials, 40% revenue growth with current treatments.

Recs

0
Member Avatar BuyouTech (< 20) Submitted: 6/1/2020 3:09:42 PM : Outperform Start Price: $66.38 NASDAQ:NVCR Score: -2.50

Proven technology that will probably be expanded to treat other types of solid tumors

Recs

0
Member Avatar tamarabenda (59.20) Submitted: 5/31/2020 5:45:30 PM : Outperform Start Price: $67.00 NASDAQ:NVCR Score: -4.02

very positive results from phase 3 trials for GBM with potential for positive results for multiple phase 3 trials for non-small cell lung cancer, ovarian cancer and pancreatic cancer that would greatly expand the addressable market. will likely not have any big news until 2022-2023 when results are released.

Leaderboard

Find the members with the highest scoring picks in NVCR.

Score Leader

oldlumike

oldlumike (41.80) Score: +471.71

The Score Leader is the player with the highest score across all their picks in NVCR.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. stcksrus 97.66 7/27/2016 Outperform 5Y $11.69 +456.54% +41.39% +415.15 0 Comment
synapse 97.46 10/20/2017 Outperform 5Y $18.25 +256.49% +19.63% +236.86 0 Comment
meridius91 95.74 10/23/2017 Outperform 5Y $18.43 +253.11% +19.42% +233.68 1 Comment
SuzyP99 82.00 8/23/2017 Outperform 1Y $18.75 +246.99% +25.69% +221.30 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. skyrocket29 62.60 8/22/2017 Outperform 1Y $19.10 +240.63% +26.08% +214.55 0 Comment
tprooney3 96.21 7/17/2017 Outperform 5Y $19.25 +237.97% +25.10% +212.87 1 Comment
XMFpessen 92.51 12/5/2017 Outperform 5Y $19.95 +226.20% +16.21% +209.99 0 Comment
only1ferret 57.09 12/6/2017 Outperform 5Y $20.08 +224.08% +16.51% +207.58 0 Comment
kaderoundy 99.11 10/8/2015 Outperform 5Y $17.98 +261.85% +54.36% +207.49 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. ATrain 83.19 12/21/2017 Outperform 5Y $20.25 +221.28% +14.70% +206.59 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NVCR.